Chk1/2 inhibition overcomes the cisplatin resistance of head and neck cancer cells secondary to the loss of functional p53 by Gadhikar, Mayur A, Sciuto, Maria Rita, Alves, Marcus Vinicius Ortega, Pickering, Curtis R, Osman, Abdullah A, Neskey, David M, Zhao, Mei, Fitzgerald, Alison L, Myers, Jeffrey N, Frederick, Mitchell J

Get full text